Cancer stem cells (CSCs) are thought to play important roles in cancer malignancy.
| INTRODUCTION
Cancer stem cells (CSCs) have been defined as a small subset of cancer cells within the tumor bulk that show potential causes of malignant properties of tumors, such as tumor initiation, metastasis, recurrence, and chemoresistance.
1,2 Expression of various CSC markers such as CD44, CD133, CD90, CD13, aldehyde dehydrogenase, and epithelial cell adhesion molecules has been identified by recent research in many solid carcinomas, suggesting a relationship with poor prognosis. [3] [4] [5] [6] [7] It was also reported that plasticity enables differentiated cancer cells to transform into cells harboring cancer stem-like properties through the epithelial-mesenchymal transition (EMT). 8, 9 Based on this concept, we have successfully induced cancer stem-like cells (CSLCs) from several cell lines using a unique medium supplemented with neural survival factor-1. [10] [11] [12] The obtained sphere CSLCs have increased resistance to several anticancer drugs. 12 Metastasis is a life-threatening systemic condition of all cancer patients. Hepatoma patients have an especially poor prognosis due to intrahepatic recurrence even after most potentially curative therapies such as surgical resection and liver transplantation. [13] [14] [15] Only a small fraction of cancer cells that survive in the systemic circulation are able to give rise to clinically relevant metastases. 16 These cells are considered CSCs and have an enhanced capacity for metastatic behavior in vitro and in vivo. [17] [18] [19] In this study, we evaluated the metastatic ability of our CSLCs by splenic injection into immune-deficient mice, and further examined metastatic potential-related features in the induced CSLCs.
| MATERIALS AND METHODS

| Cell lines
The human hepatoma SK-HEP-1 and HuH-7 cell lines were purchased from ATCC (Rockville, MD, USA) and the Health Science
Research Resources Bank (Osaka, Japan). The SK-HEP-1 and HuH-7 cell lines are from poorly and well differentiated hepatomas, respectively. Cells were cultured in DMEM (Nissui Pharmaceutical, Tokyo, Japan) containing 10% heat-inactivated FBS (Thermo Fisher Scientific, Kanagawa, Japan), penicillin (100 U/mL), streptomycin (100 lg/ mL), and sodium bicarbonate (1.5 g/L) at 37°C in a humidified atmosphere of 5% CO 2 in air.
| Induction of sphere cells
Cells were suspended in the sphere induction medium, which was based on neural stem cell medium. 12 This medium contained 2 lg/ mL heparin (Sigma-Aldrich Japan, Tokyo, Japan), 10 ng/mL human recombinant epidermal growth factor (Sigma-Aldrich), 10 ng/mL basic fibroblast growth factor (Merck Millipore, Tokyo, Japan), 10 ng/mL leukemia inhibitory factor (Merck Millipore), 60 lg/mL Nacetyl-L-cysteine (Sigma-Aldrich), and 1/50 volume neural survival factor-1 (Lonza, Tokyo, Japan) to induce floating sphere cells. 
| Splenic injection of tumor cells
| Quantitative real-time PCR
The expression levels of EMT-related genes were examined by quantitative real-time (qRT)-PCR as described previously, with minor modifications. 27 The qRT-PCR amplification was carried out using Triplicate wells were analyzed in each assay.
| Statistical analysis
Each experiment was repeated at least three times. Data are expressed as means AE SD. Significant differences were evaluated by
Fisher's exact test, or Student's or Welch's t-test, using R version 3.4.0 software (the R project website, http://www.r-project.org/). A P value <.05 was considered statistically significant.
T A B L E 1 Primers and hydrolysis probes used in this study
Gene Sequence
Hydrolysis probe UPL Probe #42 a a Universal ProbeLibrary (UPL) probe number (Roche Diagnostics, Tokyo, Japan).
3 | RESULTS
| Ability of CSLCs to metastasize to the liver
We examined the liver metastatic potential of induced CSLC SKsphere cells (Figure 1 ). NRG mice injected with 1 9 10 3 SK-sphere cells into the spleen showed an increased frequency of liver tumors compared to injection of the same number of parental SK-HEP-1 cells (P < .05). Peritoneal dissemination was observed in 4/18 (22%) of the SK-sphere cell-injected mice and 0/22 (0%) of the SK-HEP-1 cell-injected mice (P < .05). There was no difference in the frequency of liver tumors after injection of 1 9 10 4 cells. However, the areas occupied by the tumor in the cut surface of the livers were significantly increased in mice injected with SK-sphere cells compared to SK-HEP-1 cells (57 AE 26% vs 10 AE 3.4%, P < .05).
| Comprehensive mRNA expression analysis in CSLCs
Using quantitative RNA-seq analysis, we measured the comprehensive mRNA levels in both SK-sphere and parental SK-HEP-1 cells.
After normalization, the mRNA expression profiles differed between SK-sphere, parental SK-HEP-1, and non-sphere forming HuH-7 cells Table S1 ).
| Expression of EMT-related genes in CSLCs
The expression of EMT-related genes was examined by flow cytom- and SNAI1 were 2.2-and 60.7-fold higher in SK-sphere compared to SK-HEP-1 cells, respectively (P < .05; Figure 5 ). HMGA2 mRNA was also significantly upregulated in SK-sphere cells compared to parental cells (P < .05; Figure 5 ).
| Proportions of CD44 variant isoforms expressed in CSLCs
There are several isoform variants of CD44, which is a well-known cancer stem cell marker ( Figure 6A ). We evaluated the expression of each CD44 isoform variant in detail ( Figure 6B ). High mobility group AT-hook 2 (HMGA2), which is a target for let-7a-5p microRNA, is associated with high rates of metastasis, poor prognosis, and induction of the EMT in several cancers, including hepatoma. [39] [40] [41] We observed a reduced level of let-7a-5p microRNA and an elevated HMGA2 protein level in SK-sphere cells by microarray and iTRAQ-labeled 2-D liquid chromatography-tandem mass spectrometry analyses, respectively (unpublished data). Elevated HMGA2 levels were confirmed by qPCR analysis ( Figure 5 ). Overall, our results support that EMT enhances the metastatic phenotype of CSCs, although our CSLCs differed from typical liver CSCs in CD133 expression and s.c. tumorigenicity.
Hypoxia has been reported to cause drug resistance. 42,43 RNAsequencing followed by gene set enrichment analysis showed significant enrichment of not only EMT-related genes, but also hypoxiarelated genes in CSLCs ( Figure 3B ). This result corresponded to our previous report that induced chemoresistant CSLCs expressed higher HIF1A mRNA levels.
12
Gene Set Enrichment Analysis revealed that TNF-a signaling through the NF-jB signature was also enriched in CSLCs ( Figure 3A ).
In chronic myeloid leukemia stem cells and leukemia-initiating cells of acute myeloid leukemia, NF-jB activity was promoted by TNF-a secretion. 44, 45 In addition, CD24
À/low /CD44 + breast CSCs, wherein TNF signaling was enhanced, possessed higher NF-jB activity compared to non-CSCs. 46 The NF-jB-dependent stabilization of Snail in several cancer cell lines by TNF-a treatment caused EMT, which in turn increased cell invasiveness. Interestingly, in addition to CD44v8-10 isoforms, induced
CSLCs showed increased expression of a rare CD44 short-tail isoform ( Figure 6 ). The CD44 short-tail isoform had not been of interest as a research target because of its very low abundance compared with other CD44 isoforms. 53, 54 Thus, there are few reports on the CD44 short-tail isoform, and its role in cancer and
CSCs has been almost unknown. Among the few existing reports, it was shown that knockdown of the CD44 short-tail variant enhanced hyaluronan internalization and decreased cell-associated matrices in particular chondrocytes. 55 Moreover, HCCs with poor prognosis showed a greater proportion of the CD44 short-tail isoform than those with a good prognosis ( Figure S2 ). Our RNA-seq data showed that mRNA levels of GFPT1 (also known as GFAT1)
encoding glutamine-fructose-6-phosphate transaminase 1, a hexosamine biosynthetic pathway rate-limiting enzyme, were significantly higher in both CSLCs (2.2-fold) and poor prognostic HCCs (1.8-fold) compared to parental cells and good prognostic HCCs, respectively (unpublished data). Inhibition of GFPT1 by its antagonist decreased hexosamine biosynthetic pathway-dependent hyaluronic acid production, hypoxia-inducible factor-1a signaling, and CD44 high /CD24 low breast CSLC populations. 56 Taken together, the CD44 short-tail isoform might be related to CSC properties through hyaluronan metabolism and/or signaling. Further studies are needed to identify the role of the CD44 short-tail isoform in CSCs.
In conclusion, our induced CSLCs possessed metastatic in addition to chemoresistant characteristics. The EMT, and CD44 variants, including the short-tail isoform as well as the v8-10 isoforms, might correlate with the CSC phenotype. The CSLCs used in this study might be responsible for the poor prognosis of human liver cancer;
hence, further detailed investigations with the integration of CSLCs and clinical samples could disclose key therapeutic target genes for liver cancer.
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